These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35388756)

  • 1. Downregulation of CHCHD2 may Contribute to Parkinson's Disease by Reducing Expression of NFE2L2 and RQCD1.
    Li K; Ning P; Liu B; Yang H; Zhu Y; Yin W; Zhou C; Ren H; Yang X
    Curr Neurovasc Res; 2022; 19(1):19-29. PubMed ID: 35388756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA Opa interacting protein 5-antisense RNA 1 promotes mitochondrial autophagy and protects SH-SY5Y cells from 1-methyl-4-phenylpyridine-induced damage by binding to microRNA-137 and upregulating NIX.
    Zhao Y; Xie Y; Yao WY; Wang YY; Song N
    Kaohsiung J Med Sci; 2022 Mar; 38(3):207-217. PubMed ID: 35049152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHCHD2 Thr61Ile mutation impairs F1F0-ATPase assembly in
    Chen X; Lin Y; Zhang Z; Tang Y; Ye P; Dai W; Zhang W; Liu H; Peng G; Huang S; Qiu J; Guo W; Zhu X; Wu Z; Kuang Y; Xu P; Zhou M
    Neural Regen Res; 2024 Jan; 19(1):196-204. PubMed ID: 37488867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early B Cell Factor 3 (EBF3) attenuates Parkinson's disease through directly regulating contactin-associated protein-like 4 (CNTNAP4) transcription: An experimental study.
    Hu W; Wang M; Sun G; Zhang L; Lu H
    Cell Signal; 2024 Jun; 118():111139. PubMed ID: 38479556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and pharmacologic p32-inhibition rescue CHCHD2-linked Parkinson's disease phenotypes in vivo and in cell models.
    Tio M; Wen R; Choo CN; Tan JB; Chua A; Xiao B; Sundaram JR; Chan CHS; Tan EK
    J Biomed Sci; 2024 Feb; 31(1):24. PubMed ID: 38395904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHCHD2 p.Thr61Ile knock-in mice exhibit motor defects and neuropathological features of Parkinson's disease.
    Fan L; Zhang S; Li X; Hu Z; Yang J; Zhang S; Zheng H; Su Y; Luo H; Liu X; Fan Y; Sun H; Zhang Z; Miao J; Song B; Xia Z; Shi C; Mao C; Xu Y
    Brain Pathol; 2023 May; 33(3):e13124. PubMed ID: 36322611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced erythrocytic CHCHD2 mRNA is associated with brain pathology of Parkinson's disease.
    Liu X; Wang Q; Yang Y; Stewart T; Shi M; Soltys D; Liu G; Thorland E; Cilento EM; Hou Y; Liu Z; Feng T; Zhang J
    Acta Neuropathol Commun; 2021 Mar; 9(1):37. PubMed ID: 33685516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-linked CHCHD2 mutations impair CHCHD10 and MICOS complex leading to mitochondria dysfunction.
    Zhou W; Ma D; Sun AX; Tran HD; Ma DL; Singh BK; Zhou J; Zhang J; Wang D; Zhao Y; Yen PM; Goh E; Tan EK
    Hum Mol Genet; 2019 Apr; 28(7):1100-1116. PubMed ID: 30496485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHCHD2 harboring Parkinson's disease-linked T61I mutation precipitates inside mitochondria and induces precipitation of wild-type CHCHD2.
    Cornelissen T; Spinazzi M; Martin S; Imberechts D; Vangheluwe P; Bird M; De Strooper B; Vandenberghe W
    Hum Mol Genet; 2020 May; 29(7):1096-1106. PubMed ID: 32068847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CHCHD10 is involved in the development of Parkinson's disease caused by CHCHD2 loss-of-function mutation p.T61I.
    Mao C; Wang H; Luo H; Zhang S; Xu H; Zhang S; Rosenblum J; Wang Z; Zhang Q; Tang M; Shepard MJ; Wang X; Wang Y; Zhuang Z; Shi C; Xu Y
    Neurobiol Aging; 2019 Mar; 75():38-41. PubMed ID: 30530185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yin Yang 1 suppresses apoptosis and oxidative stress injury in SH-SY5Y cells by facilitating NR4A1 expression.
    Kang Q; Chai W; Min J; Qu X
    J Neurogenet; 2023; 37(4):115-123. PubMed ID: 37922205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in CHCHD2 cause α-synuclein aggregation.
    Ikeda A; Nishioka K; Meng H; Takanashi M; Hasegawa I; Inoshita T; Shiba-Fukushima K; Li Y; Yoshino H; Mori A; Okuzumi A; Yamaguchi A; Nonaka R; Izawa N; Ishikawa KI; Saiki H; Morita M; Hasegawa M; Hasegawa K; Elahi M; Funayama M; Okano H; Akamatsu W; Imai Y; Hattori N
    Hum Mol Genet; 2019 Dec; 28(23):3895-3911. PubMed ID: 31600778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SNHG1 promotes MPP
    Zhao J; Geng L; Chen Y; Wu C
    Biol Res; 2020 Jan; 53(1):1. PubMed ID: 31907031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of PGC-1α Influences Mitochondrial Signal Transduction of Dopaminergic Neurons.
    Ye Q; Huang W; Li D; Si E; Wang J; Wang Y; Chen C; Chen X
    Mol Neurobiol; 2016 Aug; 53(6):3756-3770. PubMed ID: 26141122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cx43 Mediates Resistance against MPP⁺-Induced Apoptosis in SH-SY5Y Neuroblastoma Cells via Modulating the Mitochondrial Apoptosis Pathway.
    Kim IS; Ganesan P; Choi DK
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27809287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of TFAM, NRF-1 and myr-AKT protects the MPP(+)-induced mitochondrial dysfunctions in neuronal cells.
    Piao Y; Kim HG; Oh MS; Pak YK
    Biochim Biophys Acta; 2012 May; 1820(5):577-85. PubMed ID: 21856379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-599 regulates the development of Parkinson's disease through mediating LRRK2 expression.
    Wu Q; Xi DZ; Wang YH
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):724-731. PubMed ID: 30720180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of casein kinase 1 epsilon/delta (Csnk1e/d) in the pathogenesis of familial Parkinson's disease caused by CHCHD2.
    Torii S; Arakawa S; Sato S; Ishikawa KI; Taniguchi D; Sakurai HT; Honda S; Hiraoka Y; Ono M; Akamatsu W; Hattori N; Shimizu S
    EMBO Mol Med; 2023 Sep; 15(9):e17451. PubMed ID: 37578019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHCHD2 maintains mitochondrial contact site and cristae organizing system stability and protects against mitochondrial dysfunction in an experimental model of Parkinson's disease.
    Lu L; Mao H; Zhou M; Lin Y; Dai W; Qiu J; Xiao Y; Mo M; Zhu X; Wu Z; Pei Z; Guo W; Xu P; Chen X
    Chin Med J (Engl); 2022 Jul; 135(13):1588-96. PubMed ID: 35830185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-212 Attenuates MPP⁺-Induced Neuronal Damage by Targeting KLF4 in SH-SY5Y Cells.
    Song Y; Liu Y; Chen X
    Yonsei Med J; 2018 May; 59(3):416-424. PubMed ID: 29611404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.